Connect with us

Hi, what are you looking for?


Price hikes coming if margins erode further — pharma industry


PHARMACEUTICAL manufacturers said they will have no option but to raise prices once their usual margins are halved, but for the moment they are absorbing the higher production costs.

Higinio P. Porte, Jr., Philippine Pharmaceutical Manufacturers Association (PPMA) president, said: “We hope to maintain certain margins. We cannot… be on the losing end. If we are only getting half of the standard margin, we will need to raise prices.” 

Mr. Porte, speaking on the sidelines of a briefing in Makati City last week, said surging production costs are mainly due to the weak peso.

“The cost of the raw materials and packaging materials increased by as much as 20% but we have to absorb that because we cannot just increase the price of medicine. It would be harder for consumers to afford the medicine. We are absorbing it for the meantime, hoping that this will normalize eventually,” Mr. Porte said.  

The peso closed at P57.23 against the dollar on Friday, strengthening from the Thursday level of P58.19. The peso is coming off a record low of P59 in October.

According to Mr. Porte, key imports include active pharmaceutical ingredients, which are “all imported. The only materials that are sourced locally include sugar, alcohol, and herbal pharmaceutical material like lagundi.”  

“We typically import our materials from India, China, and Europe,” he added.

Mr. Porte added that the Marcos administration should promote the export of domestically manufactured herbal drug products.

“One low-hanging fruit is to tap local requirements and export herbal drug products that only the Philippines can produce. It needs to be competitive globally in terms of safety and efficacy; that is why testing is required. The clinical testing takes five to seven years and a huge amount of investment. We are currently working with the Department of Science and Technology (DoST) to (develop) 10 herbal medicines,” Mr. Porte said.

PPMA’s members include Pascual Laboratories, Inc., Hizon Laboratories, Inc., Lejal Laboratories, Inc., Lloyd Laboratories, Inc., Interphil Laboratories, and Premier Creative Packaging, Inc. — Revin Mikhael D. Ochave

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



Data is becoming the lifeline of businesses today. Organizations are beginning to realize that they have to know how to store and manage data...


Five-dollar bills are inspected at the Bureau of Engraving and Printing in Washington, D.C., March 26, 2015. — REUTERS THE PHILIPPINES’ dollar reserves dipped...


Families enjoy taking pictures around Luneta Park in Manila, Nov. 28. Economic managers are targeting 6.5-7.5% gross domestic product growth this year, and 6-7%...


Students attend a cooking class at the Technical Education, Skills and Development Authority (TESDA) training school in Taguig City, March 23. — PHILIPPINE STAR/...


Filipino fans attend K-pop group NCT 127’s concert at the SM Mall of Asia in Pasay City, Sept. 2. Aside from NCT 127, many...


SAM WORTHINGTON in Avatar: The Way of Water LONDON — Filmmaker James Cameron is taking audiences back to his visually mesmerizing world of Pandora,...

You May Also Like


BW FILE PHOTO GROSS BORROWINGS by the National Government reached P2.6 trillion as of end-September as it continued to raise funds to respond to...


REUTERS By Luz Wendy T. Noble, Reporter The country’s foreign exchange buffers slightly increased as of end-October as the value of the central bank’s...


KARASOLAR.COM TENA, Ecuador — Ecuador’s rainforest Achuar people say their ancestors long dreamed of a “fire canoe” or “electric fish” that would let them...


COVID-19 has had a significant impact on the mental health of Filipinos across different groups all over the archipelago. From frontline workers, parents balancing...

Disclaimer: Respect, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 Respect Investment. All Rights Reserved.